Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
Anatomy of Coronary Vessels hoofdstuk lezen eerste hoofdstuk lezen

2012 | OriginalPaper | Hoofdstuk

28. Cardiovascular Disease in Women

Auteur : Margo Tolins-Mejia, MD, FACC

Gepubliceerd in: Coronary Heart Disease

Uitgeverij: Springer US

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Cardiovascular disease (CVD) is the leading cause of death in women of all age. An understanding of CVD in women is critical, especially given the aging population and the growing incidence of obesity, diabetes, and metabolic syndrome in our society. This chapter covers gender differences in risk factors for CVD, symptom presentation, and disease progression, as well as implications for diagnosis and treatment.
vorige hoofdstuk Diabetes and Coronary Heart Disease
volgende hoofdstuk Prevention of Coronary Artery Disease
Literatuur
1.
2.
Jenkins JS, Flaker GC, Nolte B, et al. Causes of higher in-hospital mortality in women than in men after acute myocardial infarction. Am J Cardiol. 1994;73(5):319–22.PubMedCrossRef
3.
Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women with diabetes. Ann Intern Med. 2007;147:149–55.PubMed
4.
Mosca L, Grundy SM, Judelson D, et al. Guide to preventative cardiology for women. AHA/ACC scientific statement. Circulation. 1999;99:2480–4.PubMedCrossRef
5.
Mosca L, Appel L, Benjamin E, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109:672–93.PubMedCrossRef
6.
Steering Committee of the Physicians’ Health Study Research Group. Final report on the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med. 1989;321:129–35.CrossRef
7.
Ridker PM, Cook NR, LeeI M, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293–304.PubMedCrossRef
8.
Kannel WB, Vokonas PS. Demographics of the prevalence, incidence and management of coronary heart disease in the elderly and in women. Ann Epidemiol. 1992;2(1):5–14.PubMedCrossRef
9.
Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.PubMedCrossRef
10.
Shaw LJ, Sharaf BL, Johnson BD, et al. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health–National Heart, Lung, and Blood Institue-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation. 2006;114:894–904.PubMedCrossRef
11.
Alexander KP, Shaw LJ, Delong ER, et al. Value of exercise treadmill testing in women. J Am Coll Cardiol. 1998;32:1657.PubMedCrossRef
12.
Nguyen JT, Berger AB, Duval S, Luepker RV. Gender disparity in cardiac procedures and medication use for acute myocardial infarction. Am Heart J. 2008;155(5):862–8.PubMedCrossRef
13.
Shaw LJ, Shaw RE, Bairey Merz CN, et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology – National Cardiovascular Data Registry. Circulation. 2008;117:1787–801.PubMedCrossRef
14.
Hochman JS, Tamis JE, Thompson TD, et al. For the global use of strategies to open occluded coronary arteries in acute coronary syndromes IIb investigators. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med. 1999;341:226–32.PubMedCrossRef
15.
Chugh SS, Uy-Evanado A, Teodorescu C, et al. Women have a lower prevalence of structural heart disease as a precursor to sudden cardiac arrest. J Am Coll Cardiol. 2009;54(22):2006–11.PubMedCrossRef
16.
BaireyMerz CN, Johnson BD, Sharaf BL, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in women evaluated for suspected ischemia: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol. 2003;41:413–9.CrossRef
17.
Egan KM, Lawson JA, Fries S, et al. COX-2-derived prostacyclin confers atheroprotection on female mice. Science. 2004;306:1954–7.PubMedCrossRef
18.
Tannebaum C, Barrett-Connor E, Laughlin GA, Platt RW. A longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: the Rancho Bernardo Study. Eur J Endocrinol. 2004;151:717–25.CrossRef
19.
Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54:2366–73.PubMedCrossRef
20.
Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383–90.PubMedCrossRef
21.
Kemp Jr HG. Left ventricular function in patients with the anginal syndrome and normal coronary angiograms. Am J Cardiol. 1973;32:375–6.PubMedCrossRef
22.
Panting JR, Gatehouse PD, Grothues F, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346:1948–53.PubMedCrossRef
23.
Wittstein IS, Thiemann DR, Lima JAC, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352:539–48.PubMedCrossRef
24.
Wong ND, Pio J, Valencia R, et al. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev Cardiol. 2001;4:109–14.PubMedCrossRef
25.
Teragawa H, Fukuda Y, Matsuda K, et al. Relation between C-reactive protein and coronary microvascular endothelial function. Heart. 2004;90(7):750–4.PubMedCrossRef
26.
Reis SE, Holubkov R, Smith AJC, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE Study. Am Heart J. 2001;141(5):735–41.PubMedCrossRef
27.
Rossi R, Nuzzo A, Origliani G, Modena MG. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol. 2008;51:997–1002.PubMedCrossRef
28.
Olson MB, Kelsey SF, Matthews K, et al. Symptoms, myocardial ischaemia, and quality of life in women: results from the NHLBI-sponsored WISE study. Eur Heart J. 2003;24:1506–14.PubMedCrossRef
29.
Johnson BD, Bairey Merz CN, Kelsey SF, et al. Persistent chest pain predicts cardiovascular events in women with and without obstructive coronary artery disease: results from the NHLBI-sponsored WISE study. Eur Heart J. 2006;27:1408–15.PubMedCrossRef
30.
Robinson JG, Wallace R, Limacher M, et al. Cardiovascular risk in women with non-specific chest pain (from the Women’s Health Initiative Hormone Trials). Am J Cardiol. 2008;102:693–9.PubMedCrossRef
31.
Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the National Institutes of Health – National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) study and the St. James Women Take Heart (WTH) project. Arch Intern Med. 2009;169:843–50.PubMedCrossRef
32.
33.
Marrugat J, Sala J, Masia R, et al. Mortality differences between men and women following first myocardial infarction. JAMA. 1998;280:1405–9.PubMedCrossRef
34.
Metagegevens
Titel
Cardiovascular Disease in Women
Auteur
Margo Tolins-Mejia, MD, FACC
Copyright
2012
Uitgeverij
Springer US
Boek
Coronary Heart Disease

Print ISBN: 978-1-4614-1474-2

Elektronisch ISBN: 978-1-4614-1475-9

Copyright: 2012

DOI
https://doi.org/10.1007/978-1-4614-1475-9_28